ישראל - עברית - Ministry of Health

j-c health care ltd - pimozide - טבליה - pimozide 4 mg - pimozide - pimozide - neuroleptic.

ישראל - עברית - Ministry of Health

vetmarket ltd, israel - pimobendan - טבליה - pimobendan 1.25 mg

ישראל - עברית - Ministry of Health

vetmarket ltd, israel - pimobendan - טבליה - pimobendan 10 mg

ישראל - עברית - Ministry of Health

vetmarket ltd, israel - pimobendan - טבליה - pimobendan 2.5 mg

ישראל - עברית - Ministry of Health

vetmarket ltd, israel - pimobendan - טבליה - pimobendan 5 mg

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

ישראל - עברית - Ministry of Health

פישר דרמה וויפס בעמ - מגבונים להסרת איפור

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - simvastatin 40 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures; reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglycerid

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - simvastatin 20 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures; reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglycerid

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - simvastatin 10 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures;reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglyceride